Sucampo Pharmaceuticals, Inc. be an emerging pharmaceutical camaraderie base inwardly Bethesda, Md. Sucampo be found in 1996 by means of Sachiko Kuno, Ph.D., the company's President and Chair of the Board of Directors, and Ryuji Ueno, M.D., Ph.D., the company's Chief Executive Officer and Chief Scientific Officer. Sucampo focus by the side of the origination and commercialization of drugs based on prostones, a meeting of merged derived from functional fatty acids that transpire smoothly in the human item. The medical quiescent of prostones was introductory identified by Dr. Ueno. In January 2006, Sucampo received marketing commendation from the FDA in favour of its first article of export, AMITIZA, for the tending of incurable idiopathic constipation in adults. In October 2004, Sucampo enter into an agreement beside Takeda Pharmaceutical Company Limited (Osaka, Japan) to co-promote and open market AMITIZA in the United States and Canada. Sucampo's specialized sale heaviness matching part the complex profession of Takeda by focus on institutional and long-term attentiveness services. Sucampo own just presently completed two pivotal Phase 3 clinical nightmare of AMITIZA for the treatment of bad-tempered bowel syndrome with constipation (IBS-C) and expect first grades in Q1 2007. Phase 3 pivotal clinical trials for the treatment of opioid-induced bowel dysfunction (OBD) be looked-for to commence in precipitate to mid 2007. To swot more going on for the company and its products, call for in Any statement here grit unshackle about anticipated expectations, dogma, and prospects for Sucampo, with statements contain the lines "estimates," "believes," "anticipates," "plans," "expects," "will," and impossible to tell apart in place of expressions, constitute forward-looking statements. Actual results may show a discrepancy materially from those indicate by such forward-looking statements accordingly of multiple factor, tons of which are ruins of our reliability. In appendage, the forward-looking statements built-in in this press release stand for our panorama beginning February 26, 2007.
About Major Depressive Disorder Major depressive disorder (MDD) is a undisputed emotional disorder, affecting nearly 121 million ancestors wide-ranging. In the United States, MDD affect something akin to 15 million adults, or 6.7 percent of the U.S. population age 18 and elder in a given year. In closeness, collapse is among the foundation cause of disability and the fourth leading contributor to the intercontinental quiet solidity of virus.
buy viagra jelly online
I prefer buying type ii diabetes in quality drugstore. Qpills - quality pills.
No comments:
Post a Comment